Target intelligence / Profile preview

ISG20L2 pseudogene 1 (ISG20L2P1)

Target
ISG20L2P1
Molecular classification
Other (Pseudogene)
01

Overview

ISG20L2 pseudogene 1 (ISG20L2P1) is a pseudogene derived from the ancestral gene ISG20L2, which encodes a 3'-5' exoribonuclease involved in ribosome biogenesis and RNA processing[1][2]. Pseudogenes like ISG20L2P1 do not code for functional protein and are generally considered to lack biological function, although rare exceptions exist. The canonical ISG20L2 gene is involved in rRNA processing and may act as a ribosome biogenesis factor involved in 18S and 5.8S pre-rRNA processing, with reported roles in cell cycle and proliferation in certain cancers[2]. However, ISG20L2P1 itself is not a recognized therapeutic, diagnostic, or research target, nor is it an active enzyme, receptor, or protein[1][2]. Key points: - ISG20L2P1 is a pseudogene, not a protein or RNA with known biological activity. - It is named for its orthology to ISG20L2, a functional exoribonuclease implicated in ribosomal RNA maturation and cell proliferation, but does not share those functions. - There is no evidence it serves as a drug target, biomarker, or has any known role in disease. - Entry of "ISG20L2 pseudogene 1" as a target is likely incorrect for therapeutic or pharmacological consideration. If you require structured information specifically about the functional gene (ISG20L2) rather than the pseudogene, further details can be provided, but this record is for a non-functional pseudogene[1][2].

Other names
ISG20L2P1ISG20L2-PS1Interferon stimulated exonuclease gene 20 like 2 pseudogene 1

Beyond the preview

Go deeper on ISG20L2 pseudogene 1 (ISG20L2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISG20L2 pseudogene 1 (ISG20L2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call